位置:首页 > 蛋白库 > IIGP1_MOUSE
IIGP1_MOUSE
ID   IIGP1_MOUSE             Reviewed;         413 AA.
AC   Q9QZ85; Q9Z1M3;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 2.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Interferon-inducible GTPase 1;
DE            EC=3.6.5.- {ECO:0000269|PubMed:12732635};
GN   Name=Iigp1; Synonyms=Irga6;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   STRAIN=C57BL/6J; TISSUE=Embryonic fibroblast, and Macrophage;
RX   PubMed=9862701;
RA   Boehm U., Guethlein L., Klamp T., Ozbek K., Schaub A., Fuetterer A.,
RA   Pfeffer K., Howard J.C.;
RT   "Two families of GTPases dominate the complex cellular response to IFN-
RT   gamma.";
RL   J. Immunol. 161:6715-6723(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=C57BL/6J; TISSUE=Splenocyte;
RX   PubMed=11907101; DOI=10.4049/jimmunol.168.7.3428;
RA   Zerrahn J., Schaible U.E., Brinkmann V., Guhlich U., Kaufmann S.H.E.;
RT   "The IFN-inducible Golgi- and endoplasmic reticulum- associated 47-kDa
RT   GTPase IIGP is transiently expressed during listeriosis.";
RL   J. Immunol. 168:3428-3436(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Muenstermann E., Schatten R., Henze S., Bohn E., Mollenhauer J.,
RA   Wiemann S., Schick M., Korn B.;
RT   "Cloning of mouse full open reading frames in Gateway(R) system entry
RT   vector (pDONR201).";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH HOOK3, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-83.
RX   PubMed=15075236; DOI=10.1242/jcs.01039;
RA   Kaiser F., Kaufmann S.H.E., Zerrahn J.;
RT   "IIGP, a member of the IFN inducible and microbial defense mediating 47 kDa
RT   GTPase family, interacts with the microtubule binding protein hook3.";
RL   J. Cell Sci. 117:1747-1756(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, PROBABLE MYRISTOYLATION AT GLY-2, AND MUTAGENESIS OF
RP   GLY-2.
RC   STRAIN=C57BL/6J;
RX   PubMed=15294976; DOI=10.4049/jimmunol.173.4.2594;
RA   Martens S., Sabel K., Lange R., Uthaiah R., Wolf E., Howard J.C.;
RT   "Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-
RT   47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced
RT   by phagocytosis.";
RL   J. Immunol. 173:2594-2606(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-82.
RC   STRAIN=C57BL/6J;
RX   PubMed=16304607; DOI=10.1371/journal.ppat.0010024;
RA   Martens S., Parvanova I., Zerrahn J., Griffiths G., Schell G.,
RA   Reichmann G., Howard J.C.;
RT   "Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-
RT   resistance GTPases.";
RL   PLoS Pathog. 1:E24-E24(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-82 AND SER-83.
RC   STRAIN=C57BL/6J;
RX   PubMed=18772884; DOI=10.1038/emboj.2008.176;
RA   Hunn J.P., Koenen-Waisman S., Papic N., Schroeder N., Pawlowski N.,
RA   Lange R., Kaiser F., Zerrahn J., Martens S., Howard J.C.;
RT   "Regulatory interactions between IRG resistance GTPases in the cellular
RT   response to Toxoplasma gondii.";
RL   EMBO J. 27:2495-2509(2008).
RN   [10]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=18784077; DOI=10.1074/jbc.m804846200;
RA   Papic N., Hunn J.P., Pawlowski N., Zerrahn J., Howard J.C.;
RT   "Inactive and active states of the interferon-inducible resistance GTPase,
RT   Irga6, in vivo.";
RL   J. Biol. Chem. 283:32143-32151(2008).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19242543; DOI=10.1371/journal.pone.0004588;
RA   Al-Zeer M.A., Al-Younes H.M., Braun P.R., Zerrahn J., Meyer T.F.;
RT   "IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia
RT   trachomatis via autophagy.";
RL   PLoS ONE 4:E4588-E4588(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas, and
RC   Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-411 IN COMPLEX WITH GTP,
RP   FUNCTION, SUBUNIT, AND CATALYTIC ACTIVITY.
RX   PubMed=12732635; DOI=10.1074/jbc.m211973200;
RA   Uthaiah R.C., Praefcke G.J.K., Howard J.C., Herrmann C.;
RT   "IIGP1, an interferon-gamma-inducible 47-kDa GTPase of the mouse, showing
RT   cooperative enzymatic activity and GTP-dependent multimerization.";
RL   J. Biol. Chem. 278:29336-29343(2003).
CC   -!- FUNCTION: GTPase with low activity. Has higher affinity for GDP than
CC       for GTP. Plays a role in resistance to intracellular pathogens.
CC       Required for disruption of the parasitophorous vacuole formed following
CC       T.gondii infection and subsequent killing of the parasite. Mediates
CC       resistance to C.trachomatis infection by targeting bacterial inclusions
CC       to autophagosomes for subsequent lysosomal destruction.
CC       {ECO:0000269|PubMed:11907101, ECO:0000269|PubMed:12732635,
CC       ECO:0000269|PubMed:16304607, ECO:0000269|PubMed:19242543}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000269|PubMed:12732635};
CC   -!- SUBUNIT: Monomer, as apoenzyme and in the GDP-bound form. Homooligomer,
CC       upon GTP binding. Interacts with HOOK3. {ECO:0000269|PubMed:12732635,
CC       ECO:0000269|PubMed:15075236, ECO:0000269|PubMed:18784077}.
CC   -!- INTERACTION:
CC       Q9QZ85; Q9QZ85: Iigp1; NbExp=2; IntAct=EBI-6910173, EBI-6910173;
CC       Q9QZ85; A1E140: ROP18; Xeno; NbExp=3; IntAct=EBI-6910173, EBI-15902261;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus membrane; Peripheral membrane
CC       protein. Endoplasmic reticulum membrane; Peripheral membrane protein.
CC       Golgi apparatus, Golgi stack membrane; Peripheral membrane protein.
CC       Parasitophorous vacuole membrane. Note=Localizes to the bacterial
CC       inclusions formed following C.trachomatis infection. Accumulates in a
CC       GTP-bound form on the parasitophorous vacuole membranes formed
CC       following T.gondii infection but exists in a GDP-bound form in
CC       uninfected cells.
CC   -!- INDUCTION: Up-regulated by IFNG, IFNA1 and lipopolysaccharide (LPS)
CC       within 20 hours. Transiently up-regulated during the early stages of
CC       infection by Listeria monocytogenes. After 6 days expression is back to
CC       basal levels. {ECO:0000269|PubMed:11907101,
CC       ECO:0000269|PubMed:9862701}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. IRG family. {ECO:0000255|PROSITE-ProRule:PRU01053,
CC       ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ007971; CAA07798.1; -; mRNA.
DR   EMBL; AF194871; AAF07195.1; -; mRNA.
DR   EMBL; AK153060; BAE31686.1; -; mRNA.
DR   EMBL; CT010300; CAJ18508.1; -; mRNA.
DR   EMBL; BC004649; AAH04649.1; -; mRNA.
DR   CCDS; CCDS29270.1; -.
DR   RefSeq; NP_001139747.1; NM_001146275.1.
DR   RefSeq; NP_068564.4; NM_021792.4.
DR   RefSeq; XP_011245279.1; XM_011246977.2.
DR   RefSeq; XP_011245280.1; XM_011246978.2.
DR   RefSeq; XP_011245281.1; XM_011246979.2.
DR   RefSeq; XP_011245282.1; XM_011246980.1.
DR   PDB; 1TPZ; X-ray; 2.00 A; A/B=1-411.
DR   PDB; 1TQ2; X-ray; 2.70 A; A/B=1-411.
DR   PDB; 1TQ4; X-ray; 1.95 A; A=1-413.
DR   PDB; 1TQ6; X-ray; 2.70 A; A=1-413.
DR   PDB; 1TQD; X-ray; 2.30 A; A/B=1-413.
DR   PDB; 4LV5; X-ray; 1.70 A; B=1-413.
DR   PDB; 4LV8; X-ray; 1.72 A; B=1-413.
DR   PDB; 5FPH; X-ray; 3.20 A; A/B/C/D/E/F/G=1-413.
DR   PDBsum; 1TPZ; -.
DR   PDBsum; 1TQ2; -.
DR   PDBsum; 1TQ4; -.
DR   PDBsum; 1TQ6; -.
DR   PDBsum; 1TQD; -.
DR   PDBsum; 4LV5; -.
DR   PDBsum; 4LV8; -.
DR   PDBsum; 5FPH; -.
DR   AlphaFoldDB; Q9QZ85; -.
DR   SMR; Q9QZ85; -.
DR   BioGRID; 208563; 4.
DR   CORUM; Q9QZ85; -.
DR   DIP; DIP-58958N; -.
DR   IntAct; Q9QZ85; 2.
DR   STRING; 10090.ENSMUSP00000032473; -.
DR   iPTMnet; Q9QZ85; -.
DR   MetOSite; Q9QZ85; -.
DR   PhosphoSitePlus; Q9QZ85; -.
DR   SwissPalm; Q9QZ85; -.
DR   EPD; Q9QZ85; -.
DR   jPOST; Q9QZ85; -.
DR   PaxDb; Q9QZ85; -.
DR   PRIDE; Q9QZ85; -.
DR   ProteomicsDB; 267305; -.
DR   DNASU; 60440; -.
DR   Ensembl; ENSMUST00000032473; ENSMUSP00000032473; ENSMUSG00000054072.
DR   Ensembl; ENSMUST00000066912; ENSMUSP00000063390; ENSMUSG00000054072.
DR   Ensembl; ENSMUST00000237185; ENSMUSP00000157568; ENSMUSG00000054072.
DR   GeneID; 60440; -.
DR   KEGG; mmu:60440; -.
DR   UCSC; uc008fac.2; mouse.
DR   CTD; 60440; -.
DR   MGI; MGI:1926259; Iigp1.
DR   VEuPathDB; HostDB:ENSMUSG00000054072; -.
DR   eggNOG; ENOG502QS9R; Eukaryota.
DR   GeneTree; ENSGT00950000183007; -.
DR   HOGENOM; CLU_015342_2_0_1; -.
DR   InParanoid; Q9QZ85; -.
DR   OMA; NDMKLAK; -.
DR   OrthoDB; 688334at2759; -.
DR   PhylomeDB; Q9QZ85; -.
DR   TreeFam; TF331897; -.
DR   BioGRID-ORCS; 60440; 4 hits in 70 CRISPR screens.
DR   ChiTaRS; Iigp1; mouse.
DR   EvolutionaryTrace; Q9QZ85; -.
DR   PRO; PR:Q9QZ85; -.
DR   Proteomes; UP000000589; Chromosome 18.
DR   RNAct; Q9QZ85; protein.
DR   Bgee; ENSMUSG00000054072; Expressed in heart right ventricle and 194 other tissues.
DR   ExpressionAtlas; Q9QZ85; baseline and differential.
DR   Genevisible; Q9QZ85; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020005; C:symbiont-containing vacuole membrane; IDA:UniProtKB.
DR   GO; GO:0019003; F:GDP binding; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:MGI.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IDA:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:MGI.
DR   GO; GO:0006952; P:defense response; IBA:GO_Central.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProtKB.
DR   GO; GO:0042832; P:defense response to protozoan; IDA:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IEP:MGI.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR030385; G_IRG_dom.
DR   InterPro; IPR007743; Immunity-related_GTPase-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF05049; IIGP; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51716; G_IRG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Endoplasmic reticulum; Golgi apparatus;
KW   GTP-binding; Hydrolase; Immunity; Innate immunity; Lipoprotein; Membrane;
KW   Myristate; Nucleotide-binding; Nucleus; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..413
FT                   /note="Interferon-inducible GTPase 1"
FT                   /id="PRO_0000223527"
FT   DOMAIN          68..250
FT                   /note="IRG-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01053"
FT   BINDING         77..84
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:12732635"
FT   BINDING         102..106
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:12732635"
FT   BINDING         184..186
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:12732635"
FT   BINDING         231..233
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000269|PubMed:12732635"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         2
FT                   /note="G->A: Protein is detected exclusively in the aqueous
FT                   phase."
FT                   /evidence="ECO:0000269|PubMed:15294976"
FT   MUTAGEN         82
FT                   /note="K->A: Constitutively active. Binds GTP but fails to
FT                   hydrolyze it. Does not localize to the parasitophorous
FT                   vacuole membrane following T.gondii infection."
FT                   /evidence="ECO:0000269|PubMed:16304607,
FT                   ECO:0000269|PubMed:18772884"
FT   MUTAGEN         83
FT                   /note="S->N: Abrogates interaction with HOOK3. Greatly
FT                   reduces binding affinity for GDP and GTP. Abolishes GTP-
FT                   dependent oligomer formation."
FT                   /evidence="ECO:0000269|PubMed:15075236,
FT                   ECO:0000269|PubMed:18772884"
FT   CONFLICT        138
FT                   /note="N -> D (in Ref. 2; AAF07195)"
FT                   /evidence="ECO:0000305"
FT   HELIX           16..25
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           29..31
FT                   /evidence="ECO:0007829|PDB:1TQ4"
FT   HELIX           36..47
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           51..66
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          70..75
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           82..90
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          94..96
FT                   /evidence="ECO:0007829|PDB:1TPZ"
FT   HELIX           104..108
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          112..115
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          122..126
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           130..132
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           137..143
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           146..148
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          150..159
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           162..173
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          179..183
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           185..195
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   TURN            197..199
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           202..219
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:5FPH"
FT   STRAND          227..229
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   TURN            233..236
FT                   /evidence="ECO:0007829|PDB:1TQD"
FT   STRAND          237..239
FT                   /evidence="ECO:0007829|PDB:1TQ2"
FT   HELIX           240..249
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           253..255
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           256..262
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           268..288
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          292..294
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           303..319
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           324..333
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           338..342
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           347..349
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          355..357
FT                   /evidence="ECO:0007829|PDB:1TQ2"
FT   HELIX           359..374
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   STRAND          377..379
FT                   /evidence="ECO:0007829|PDB:4LV5"
FT   HELIX           386..409
FT                   /evidence="ECO:0007829|PDB:4LV5"
SQ   SEQUENCE   413 AA;  47572 MW;  44B5A95FCA58A37A CRC64;
     MGQLFSSPKS DENNDLPSSF TGYFKKFNTG RKIISQEILN LIELRMRKGN IQLTNSAISD
     ALKEIDSSVL NVAVTGETGS GKSSFINTLR GIGNEEEGAA KTGVVEVTME RHPYKHPNIP
     NVVFWDLPGI GSTNFPPNTY LEKMKFYEYD FFIIISATRF KKNDIDIAKA ISMMKKEFYF
     VRTKVDSDIT NEADGKPQTF DKEKVLQDIR LNCVNTFREN GIAEPPIFLL SNKNVCHYDF
     PVLMDKLISD LPIYKRHNFM VSLPNITDSV IEKKRQFLKQ RIWLEGFAAD LVNIIPSLTF
     LLDSDLETLK KSMKFYRTVF GVDETSLQRL ARDWEIEVDQ VEAMIKSPAV FKPTDEETIQ
     ERLSRYIQEF CLANGYLLPK NSFLKEIFYL KYYFLDMVTE DAKTLLKEIC LRN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024